Skip to main content
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1981 Jul;33(4):592–605.

Prevention of homozygous beta-thalassemia by carrier screening and prenatal diagnosis in Sardinia.

A Cao, M Furbetta, R Galanello, M A Melis, A Angius, A Ximenes, C Rosatelli, R Ruggeri, M Addis, T Tuveri, A M Falchi, E Paglietti, M T Scalas
PMCID: PMC1685095  PMID: 7258188

Abstract

We report here results of a 3-year pilot voluntary screening program coupled with prenatal diagnosis directed to the prospective prevention of homozygous beta-thalassemia (beta-thal) in Sardinia. The screening program took two approaches: outreach community testing and hospital testing on request after a period of sensibilization. The outreach testing was very effective as, taking into account the already known number of couples at risk with an affected proband (20), 74% of the couple at risk expected (61) on the basis of the carrier rate were identified. Less effective was the hospital testing in which half of the couples at risk expected were detected (502 with the 199 without an affected proband). After nondirective genetic counseling, approximately 85% of the couples at risk, which had a pregnancy, with no statistically significant difference between those with and those without a proband, requested prenatal testing. This figure showed a steadily increase from the beginning in 1977 to 1980. All the pregnancies (42), but two carrying homozygous fetuses, were terminated on parental request. A continuous hospital survey of thal-major admissions in the different hospitals of the counties showed a steady decline in the incidence figure at birth from 1976 (1:213) to 1978 (1:290). These results showed that even in a medium-developed, rural, Catholic population screening coupled with prenatal diagnosis can be successful in the control of a fatal, recessively inherited disorder.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alter B. P., Modell C. B., Fairweather D., Hobbins J. C., Mahoney M. J., Frigoletto F. D., Sherman A. S., Nathan D. G. Prenatal diagnosis of hemoglobinopathies. A review of 15 cases. N Engl J Med. 1976 Dec 23;295(26):1437–1443. doi: 10.1056/NEJM197612232952601. [DOI] [PubMed] [Google Scholar]
  2. BETKE K., MARTI H. R., SCHLICHT I. Estimation of small percentages of foetal haemoglobin. Nature. 1959 Dec 12;184(Suppl 24):1877–1878. doi: 10.1038/1841877a0. [DOI] [PubMed] [Google Scholar]
  3. Barrai I., Vullo C. Genetic counselling in beta thalassemia in Ferrara. J Genet Hum. 1980 Jun;28(2):97–104. [PubMed] [Google Scholar]
  4. Beutler E., Boggs D. R., Heller P., Maurer A., Motulsky A. G., Sheehy T. W. Hazards of indiscriminate screening for sickling. N Engl J Med. 1971 Dec 23;285(26):1485–1486. doi: 10.1056/NEJM197112232852612. [DOI] [PubMed] [Google Scholar]
  5. Boyer S. H., Noyes A. N., Boyer M. L. Enrichment of erythrocytes of fetal origin from adult-fetal blood mixtures via selective hemolysis of adult blood cells: an aid to antenatal diagnosis of hemoglobinopathies. Blood. 1976 Jun;47(6):883–897. [PubMed] [Google Scholar]
  6. Cao A., Furbetta M., Angius A., Ximenes A., Angioni G., Caminiti F. Prenatal diagnosis of beta thalassemia: experience with 133 cases and the effect of fetal blood sampling on child development. Ann N Y Acad Sci. 1980;344:165–180. doi: 10.1111/j.1749-6632.1980.tb33659.x. [DOI] [PubMed] [Google Scholar]
  7. Cao A., Galanello R., Furbetta M., Muroni P. P., Garbato L., Rosatelli C., Scalas M. T., Addis M., Ruggeri R., Maccioni L. Thalassaemia types and their incidence in Sardinia. J Med Genet. 1978 Dec;15(6):443–447. doi: 10.1136/jmg.15.6.443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Duncombe D. C., Lowell L. K., Mahoney M. J., Papazian H. P., Tropp R., Bowman J. E. Ethical issues in genetic screening. N Engl J Med. 1972 Jul 27;287(4):204–205. doi: 10.1056/NEJM197207272870431. [DOI] [PubMed] [Google Scholar]
  9. Fairweather D. V., Modell B., Berdoukas V., Alter B. P., Nathan D. G., Loukopoulos D., Wood W., Clegg J. B., Weatherall D. J. Antenatal diagnosis of thalassaemia major. Br Med J. 1978 Feb 11;1(6109):350–353. doi: 10.1136/bmj.1.6109.350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fairweather D. V., Ward R. H., Modell B. Obstetric aspects of midtrimester fetal blood sampling by needling or fetoscopy. Br J Obstet Gynaecol. 1980 Feb;87(2):87–99. doi: 10.1111/j.1471-0528.1980.tb04499.x. [DOI] [PubMed] [Google Scholar]
  11. Fost N., Kaback N. M. Why do sickle screening in children? Pediatrics. 1973 Apr;51(4):742–745. [PubMed] [Google Scholar]
  12. Furbetta M., Angius A., Ximenes A., Fais R., Cao A., Valenti C., Fioretti P., Caminiti F., Angioni G., Nasi A. Prenatal diagnosis of beta-thalassemia. Experience with 24 cases. Isr J Med Sci. 1978 Nov;14(11):1107–1110. [PubMed] [Google Scholar]
  13. Furbetta M., Angius A., Ximenes A., Tuveri T., Rosatelli C., Scalas M. T., Fais R., Cao A., Angioni G., Caminiti F. Prenatal diagnosis of beta thalassaemia by fetal red cell enrichment with NH4-Cl-NH4HCO3 differential lysis of maternal cells. Br J Haematol. 1980 Mar;44(3):441–450. doi: 10.1111/j.1365-2141.1980.tb05914.x. [DOI] [PubMed] [Google Scholar]
  14. Galanello R., Melis M. A., Muroni P., Cao A. Quantitation of Hb a2 with DE-52 microchromatography in whole blood as screening test for beta-thalassemia heterozygotes. Acta Haematol. 1977;57(1):32–36. doi: 10.1159/000207857. [DOI] [PubMed] [Google Scholar]
  15. Galanello R., Melis M. A., Ruggeri R., Addis M., Scalas M. T., Maccioni L., Furbetta M., Angius A., Tuveri T., Cao A. Beta 0 thalassemia trait in Sardinia. Hemoglobin. 1979;3(1):33–46. doi: 10.3109/03630267909069153. [DOI] [PubMed] [Google Scholar]
  16. Hampton M. L., Anderson J., Lavizzo B. S., Bergmen A. B. Sickle cell "nondisease". A potentially serious public health problem. Am J Dis Child. 1974 Jul;128(1):58–61. [PubMed] [Google Scholar]
  17. Headings V., Fielding J. Guidelines for counseling young adults with sickle cell trait. Am J Public Health. 1975 Aug;65(8):819–827. doi: 10.2105/ajph.65.8.819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Huisman T. H., Schroeder W. A., Brodie A. N., Mayson S. M., Jakway J. Microchromatography of hemoglobins. II. A simplified procedure for the determination of hemoglobin A2. J Lab Clin Med. 1975 Oct;86(4):700–702. [PubMed] [Google Scholar]
  19. KLEIHAUER E., BRAUN H., BETKE K. Demonstration von fetalem Hämoglobin in den Erythrocyten eines Blutausstrichs. Klin Wochenschr. 1957 Jun 15;35(12):637–638. doi: 10.1007/BF01481043. [DOI] [PubMed] [Google Scholar]
  20. Kaback M. M., Zeiger R. S., Reynolds L. W., Sonneborn M. Approaches to the control and prevention of Tay-Sachs disease. Prog Med Genet. 1974;10:103–134. [PubMed] [Google Scholar]
  21. Kan Y. W., Golbus M. S., Trecartin R. Prenatal diagnosis of homozygous beta-thalassaemia. Lancet. 1975 Oct 25;2(7939):790–791. [PubMed] [Google Scholar]
  22. Kan Y. W., Trecartin R. F., Golbus M. S., Filly R. A. Prenatal diagnosis of beta-thalassaemia and sickle-cell anaemia. Experience with 24 cases. Lancet. 1977 Feb 5;1(8006):269–271. doi: 10.1016/s0140-6736(77)91821-9. [DOI] [PubMed] [Google Scholar]
  23. Lauber K. Bestimmung von Serumeisen und Eisenbindungskapazität ohne Enteiweissung. Z Klin Chem Klin Biochem. 1965 Jun;3(3):96–99. [PubMed] [Google Scholar]
  24. Melis M. A., Rosatelli C., Falchi A. M., Angius A., Furbetta M., Galanello R., Cao A. Hematological characteristics of sardinian alpha-thalassemia carriers detected in a population study. Acta Haematol. 1980;63(1):32–36. doi: 10.1159/000207365. [DOI] [PubMed] [Google Scholar]
  25. Midtrimester amniocentesis for prenatal diagnosis. Safety and accuracy. JAMA. 1976 Sep 27;236(13):1471–1476. doi: 10.1001/jama.1976.03270140023016. [DOI] [PubMed] [Google Scholar]
  26. Modell B. Management of thalassaemia major. Br Med Bull. 1976 Sep;32(3):270–276. doi: 10.1093/oxfordjournals.bmb.a071374. [DOI] [PubMed] [Google Scholar]
  27. Motulsky A. G. Brave new world? Science. 1974 Aug;185(4152):653–663. doi: 10.1126/science.185.4152.653. [DOI] [PubMed] [Google Scholar]
  28. Pembrey M. E., McWade P., Weatherall D. J. Reliable routine estimation of small amounts of foetal haemoglobin by alkali denaturation. J Clin Pathol. 1972 Aug;25(8):738–740. doi: 10.1136/jcp.25.8.738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Rowley P. T., Fisher L., Lipkin M., Jr Screening and genetic counseling for beta-thalassemia trait in a population unselected for interest: effects on knowledge and mood. Am J Hum Genet. 1979 Nov;31(6):718–730. [PMC free article] [PubMed] [Google Scholar]
  30. Rucknagel D. L. The genetics of sickle cell anemia and related syndromes. Arch Intern Med. 1974 Apr;133(4):595–606. [PubMed] [Google Scholar]
  31. Rutkow I. M., Lipton J. M. Some negative aspects of state health departments' policies related to screening for sickle cell anemia. Am J Public Health. 1974 Mar;64(3):217–221. doi: 10.2105/ajph.64.3.217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Schmidt R. M. Hemoglobinopathy screening: approaches to diagnosis, education and counseling. Am J Public Health. 1974 Aug;64(8):799–804. doi: 10.2105/ajph.64.8.799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Shine I., Lal S. A strategy to detect beta-thalassaemia minor. Lancet. 1977 Mar 26;1(8013):692–694. doi: 10.1016/s0140-6736(77)92128-6. [DOI] [PubMed] [Google Scholar]
  34. Whitten C. F. Sickle-cell programming--an imperiled promise. N Engl J Med. 1973 Feb 8;288(6):318–319. doi: 10.1056/NEJM197302082880612. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES